Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms

C C Blyth, A J Currie, S P Wiertsema, N. Conway, L A S Kirkham, A Fuery, F Mascaro, G C Geelhoed, P C Richmond

    Research output: Contribution to journalArticle

    39 Citations (Scopus)

    Abstract

    Increased numbers of children presenting with febrile adverse events following trivalent influenza vaccine (TIV) were noted in Australia in 2010. We describe the epidemiology and clinical features of the adverse events and explore the biological basis for the adverse events using an in vitro model.
    Original languageEnglish
    Pages (from-to)5107-5113
    Number of pages7
    JournalVaccine
    Volume29
    Issue number32
    DOIs
    Publication statusPublished - 2011

    Fingerprint Dive into the research topics of 'Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms'. Together they form a unique fingerprint.

  • Cite this

    Blyth, C. C., Currie, A. J., Wiertsema, S. P., Conway, N., Kirkham, L. A. S., Fuery, A., Mascaro, F., Geelhoed, G. C., & Richmond, P. C. (2011). Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine, 29(32), 5107-5113. https://doi.org/10.1016/j.vaccine.2011.05.054